Volume 52, Issue 3, Pages (September 2007)

Slides:



Advertisements
Similar presentations
Volume 42, Issue 1, Pages 7-11 (July 2002)
Advertisements

Volume 50, Issue 3, Pages (September 2006)
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Volume 72, Issue 1, Pages (January 2017)
Volume 68, Issue 3, Pages (September 2015)
Volume 52, Issue 1, Pages (July 2007)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Achieving the Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management  Michael O’Leary  European Urology Supplements 
Testosterone Therapy in Men With Prostate Cancer
Management of Acute and Chronic Retention in Men
Volume 54, Issue 6, Pages (December 2008)
Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction  Steven A. Kaplan,
Volume 61, Issue 6, Pages (June 2012)
Volume 60, Issue 6, Pages (December 2011)
Volume 52, Issue 2, Pages (August 2007)
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Prostate Cancer Epidemic in Sight?
Rowland Illing  European Urology Supplements 
Volume 53, Issue 2, Pages (February 2008)
Volume 55, Issue 2, Pages (February 2009)
Volume 46, Issue 4, Pages (October 2004)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Back to the Future: Introduction and Conclusions
Sexual Dysfunction and Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH)  Raymond C. Rosen, Francois Giuliano, Culley.
Volume 51, Issue 1, Pages (January 2007)
Volume 54, Issue 4, Pages (October 2008)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Prostate Cancer Detection: A View of the Future
Rowland Illing  European Urology Supplements 
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Volume 60, Issue 1, Pages (July 2011)
Volume 56, Issue 1, Pages (July 2009)
Volume 58, Issue 3, Pages (September 2010)
Volume 60, Issue 4, Pages (October 2011)
Volume 61, Issue 3, Pages (March 2012)
Counselling the Prostate Cancer Patient
Volume 52, Issue 4, Pages (October 2007)
Prostate Cancer Epidemic in Sight?
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old  P. Perrin,
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Richard C. Harkaway  European Urology Supplements 
Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl  European Urology 
Volume 50, Issue 3, Pages (September 2006)
Volume 50, Issue 5, Pages (November 2006)
Volume 46, Issue 5, Pages (November 2004)
Tim Schneider  European Urology Supplements 
Volume 74, Issue 5, Pages (November 2018)
Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH):
Volume 54, Issue 6, Pages (December 2008)
Volume 53, Issue 6, Pages (June 2008)
What are the Data on 5α-Reductase Inhibitor Treatment of Benign Prostatic Hyperplasia from Everyday Practice?  François Desgrandchamps  European Urology.
European Urology is “Your” Journal
Volume 65, Issue 6, Pages (June 2014)
Emmanuel Chartier-Kastler, Kate Davidson  European Urology Supplements 
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.
Martin Michel, Jean de la Rosette  European Urology Supplements 
How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?  Vincenzo Mirone 
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Volume 52, Issue 6, Pages (December 2007)
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Integrating Patient Risk Profiles in the Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) in Clinical Practice 
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Michael Marberger  European Urology Supplements 
Vassilios Tzortzis, Stavros Gravas, Jean J.M.C.H. de la Rosette 
Presentation transcript:

Volume 52, Issue 3, Pages 819-826 (September 2007) Clinical Relevance of Transurethral Resection of the Prostate in “Asymptomatic” Patients with an Elevated Prostate-Specific Antigen Level  Koenraad van Renterghem, Gommert Van Koeveringe, Ruth Achten, Philip Van Kerrebroeck  European Urology  Volume 52, Issue 3, Pages 819-826 (September 2007) DOI: 10.1016/j.eururo.2007.03.055 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 Mean International Prostate Symptom Score (SE) within different prostate-specific antigen categories and in the total population of clinical patients with benign prostatic hyperplasia/benign prostatic enlargement at baseline and after transurethral resection of the prostate. European Urology 2007 52, 819-826DOI: (10.1016/j.eururo.2007.03.055) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 2 Percentage of clinical patients with benign prostatic hyperplasia/benign prostatic enlargement with mild (International Prostate Symptom Score [IPSS] ≤7) or moderate (IPSS 8–18) lower urinary tract symptoms at baseline and after transurethral resection of the prostate. European Urology 2007 52, 819-826DOI: (10.1016/j.eururo.2007.03.055) Copyright © 2007 European Association of Urology Terms and Conditions